Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-23T11:17:02.528Z Has data issue: false hasContentIssue false
  • English
  • Français

Association between serum iron, blood lead, cadmium, mercury, selenium, manganese and low cognitive performance in old adults from National Health and Nutrition Examination Survey (NHANES): a cross-sectional study

Published online by Cambridge University Press:  21 March 2023

Kui Lu ,
Tian Liu ,
Xiaoyan Wu ,
Jianqiang Zhong ,
Zhenri Ou  and
Wenjun Wu Open the ORCID record for Wenjun Wu [Opens in a new window]
Kui Lu
Affiliation:
Department of Neurology, Zhongshan City People’s Hospital, Zhongshan 528403, Guangdong, People’s Republic of China
Tian Liu
Affiliation:
President's Office, Zhongshan City People’s Hospital, Zhongshan 528403, Guangdong, People’s Republic of China
Xiaoyan Wu
Affiliation:
Department of Neurology, the Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou 511300, Guangdong, People’s Republic of China
Jianqiang Zhong
Affiliation:
Department of Neurology, the Fourth Affiliated Hospital of Guangzhou Medical University, Guangzhou 511300, Guangdong, People’s Republic of China
Zhenri Ou
Affiliation:
Department of Neurology, Zhongshan City People’s Hospital, Zhongshan 528403, Guangdong, People’s Republic of China
Wenjun Wu*
Affiliation:
Department of Neurology, Zhongshan City People’s Hospital, Zhongshan 528403, Guangdong, People’s Republic of China
*
*Corresponding author: Wenjun Wu, email wuwenjun_neur@outlook.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Cognitive decline is a public health problem for the world’s ageing population. This study was to evaluate the relationships between serum Fe, blood Pb, Cd, Hg, Se and Mn and cognitive decline in elderly Americans. Data of this cross-sectional study were extracted from the National Health and Nutritional Examination Survey (NHANES 2011–2014). Cognitive performance was measured by the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD), Animal Fluency and Digit Symbol Substitution Test (DSST) tests. Weighted univariable and multivariate logistic regression analyses were used to assess the associations between six trace elements and low cognitive performance. Subgroup analyses based on diabetes and hypertension history were further assessed the associations. A total of 2002 adults over 60 years old were included. After adjusting covariates, elevated serum Fe levels were associated with the decreased risk of low cognitive performance, especially in the elderly without diabetes history and with hypertension history. High blood Cd levels were associated with the high odds of low cognitive performance in old adults with diabetes and hypertension history. Elevated blood Mn levels were connected with low cognitive performance in old hypertensive people. High blood Pb levels were related to the high odds of low cognitive performance, especially in the elderly without diabetes and hypertension history. High blood Se levels were linked to the decreased risk of low cognitive performance in all the elderly. Appropriate Fe, Se supplementation and Fe-, Se-rich foods intake, while reducing exposure to Pb, Cd and Mn may be beneficial for cognitive function in the elderly.

Keywords

Low cognitive performanceTrace elementsNHANES database
Type
Research Article
Information
British Journal of Nutrition , Volume 130 , Issue 10 , 28 November 2023 , pp. 1743 - 1753
Check for updates
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Nutrition Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Pais, R, Ruano, L, Moreira, C, et al. (2020) Prevalence and incidence of cognitive impairment in an elder Portuguese population (65–85 years old). BMC Geriatr 20, 470.10.1186/s12877-020-01863-7CrossRefGoogle Scholar
States A (2013) The Healthy Brain Initiative: the Public Health Road Map for State and National Partnerships, 2013–2018. Aging/Physiology/United States. https://stacks.cdc.gov/view/cdc/24905 (accessed June 2022).Google Scholar
Park, MH, Kwon, DY, Jung, JM, et al. (2013) Mini-mental status examination as predictors of mortality in the elderly. Acta Psychiatr Scand 127, 298–304.10.1111/j.1600-0447.2012.01918.xCrossRefGoogle ScholarPubMed
Alzheimer’s Association (2016) 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 12, 459–509.10.1016/j.jalz.2016.03.001CrossRefGoogle Scholar
Alzheimer’s Association (2020) 2020 Alzheimer’s disease facts and figures. Alzheimers Dement 16, 391–460.10.1002/alz.12068CrossRefGoogle Scholar
Nichols, E, Szoeke, CEI, Vollset, SE, et al. (2019) Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18, 88–106.10.1016/S1474-4422(18)30403-4CrossRefGoogle Scholar
Belaidi, AA & Bush, AI (2016) Iron neurochemistry in Alzheimer’s disease and Parkinson’s disease: targets for therapeutics. J Neurochem 139, 179–197.10.1111/jnc.13425CrossRefGoogle ScholarPubMed
Horning, KJ, Caito, SW, Tipps, KG, et al. (2015) Manganese is essential for neuronal health. Annu Rev Nutr 35, 71–108.10.1146/annurev-nutr-071714-034419CrossRefGoogle ScholarPubMed
Duce, JA & Bush, AI (2010) Biological metals and Alzheimer’s disease: implications for therapeutics and diagnostics. Prog Neurobiol 92, 1–18.10.1016/j.pneurobio.2010.04.003CrossRefGoogle ScholarPubMed
Tardy, AL, Pouteau, E, Marquez, D, et al. (2020) Vitamins and minerals for energy, fatigue and cognition: a narrative review of the biochemical and clinical evidence. Nutrients 12, 228.10.3390/nu12010228CrossRefGoogle ScholarPubMed
Ferry, M & Roussel, AM (2011) Micronutrient status and cognitive decline in ageing. Eur Geriatr Med 2, 15–21.10.1016/j.eurger.2010.11.014CrossRefGoogle Scholar
Gao, S, Jin, Y, Hall, KS, et al. (2009) Selenium level is associated with apoE ϵ4 in rural elderly Chinese. Public Health Nutr 12, 2371–2376.10.1017/S1368980009005102CrossRefGoogle Scholar
Lonnerdal, B (2017) Development of iron homeostasis in infants and young children. Am J Clin Nutr 106, 1575S–1580S.10.3945/ajcn.117.155820CrossRefGoogle ScholarPubMed
Karri, V, Schuhmacher, M & Kumar, V (2016) Heavy metals (Pb, Cd, As and MeHg) as risk factors for cognitive dysfunction: a general review of metal mixture mechanism in brain. Environ Toxicol Pharmacol 48, 203–213.10.1016/j.etap.2016.09.016CrossRefGoogle ScholarPubMed
Meramat, A, Rajab, NF, Shahar, S, et al. (2017) DNA damage, copper and lead associates with cognitive function among older adults. J Nutr Health Aging 21, 539.10.1007/s12603-016-0759-1CrossRefGoogle ScholarPubMed
Schampaert, E, Cohen, EA, Schluter, M, et al. (2004) The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43, 1110–1115.10.1016/j.jacc.2004.01.024CrossRefGoogle Scholar
National Health and Nutrition Examination Survey 2011–2012 Data Documentation, codebook and Frequencies, Cognitive Functioning. Published in March 2017 https://www.cdc.gov/Nchs/Nhanes/2011–2012/CFQ_G.htm (accessed January 2022).Google Scholar
National Health and Nutrition Examination Survey 2013–2014 Data Documentation, Codebook and Frequencies, Cognitive Functioning. Published in March 2017 https://www.cdc.gov/Nchs/Nhanes/2013–2014/CFQ_H.htm (accessed January 2022).Google Scholar
Morris, JC, Mohs, RC, Rogers, H, et al. (1988) Consortium to establish a registry for Alzheimer’s Disease (CERAD) clinical and neuropsychological assessment of Alzheimer’s disease. Psychopharmacol Bull 24, 641–652.Google ScholarPubMed
Wechsler, D (1997) Wechsler Adult Intelligence Scale, 3rd ed. Boston, MA: Springer.Google Scholar
Dong, X, Li, S, Chen, J, et al. (2020) Association of dietary n-3 and n-6 fatty acids intake with cognitive performance in older adults: national health and nutrition examination Survey (NHANES) 2011–2014. Nutr J 19, 25.10.1186/s12937-020-00547-7CrossRefGoogle Scholar
Chen, SP, Bhattacharya, J & Pershing, S (2017) Association of vision loss with cognition in older adults. JAMA Ophthalmol 135, 963–970.10.1001/jamaophthalmol.2017.2838CrossRefGoogle ScholarPubMed
Butnariu, M (2012) The oxygen paradox. J Pharmacogenomics Pharmacoproteomics 3, 1–3.10.4172/2153-0645.1000e104CrossRefGoogle Scholar
Kweon, OJ, Youn, YC, Lim, YK, et al. (2019) Clinical utility of serum hepcidin and iron profile measurements in Alzheimer’s disease. J Neurol Sci 403, 85–91.10.1016/j.jns.2019.06.008CrossRefGoogle ScholarPubMed
Hare, DJ, Doecke, JD, Faux, NG, et al. (2015) Decreased plasma iron in Alzheimer’s disease is due to transferrin desaturation. ACS Chem Neurosci 6, 398–402.10.1021/cn5003557CrossRefGoogle ScholarPubMed
Kim, Y & Connor, JR (2020) The roles of iron and HFE genotype in neurological diseases. Mol Aspects Med 75, 100867.10.1016/j.mam.2020.100867CrossRefGoogle ScholarPubMed
Puig, S, Ramos-Alonso, L, Romero, AM, et al. (2017) The elemental role of iron in DNA synthesis and repair. Metallomics 9, 1483–1500.10.1039/C7MT00116ACrossRefGoogle ScholarPubMed
Ying, H & Zhang, Y (2019) Systems biology of selenium and complex disease. Biol Trace Elem Res 192, 38–50.10.1007/s12011-019-01781-9CrossRefGoogle ScholarPubMed
Vaz, FNC, Fermino, BL, Haskel, MVL, et al. (2018) The relationship between copper, iron, and selenium levels and Alzheimer disease. Biol Trace Elem Res 181, 185–191.10.1007/s12011-017-1042-yCrossRefGoogle ScholarPubMed
Cardoso, BR, Ong, TP, Jacob-Filho, W, et al. (2010) Nutritional status of selenium in Alzheimer’s disease patients. Br J Nutr 103, 803–806.10.1017/S0007114509992832CrossRefGoogle ScholarPubMed
Navarro-Alarcón, M, Serrana, L, Pérez-Valero, V, et al. (1999) Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci Total Environ 228, 79–85.10.1016/S0048-9697(99)00034-0CrossRefGoogle ScholarPubMed
Spauwen, PJ, Eupen, MV, Köhler, S, et al. (2015) Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: the Maastricht study. J Clin Endocrinol Metab 100, 951–960.10.1210/jc.2014-2754CrossRefGoogle ScholarPubMed
Klimova, B, Kuca, K & Maresova, P (2018) Global view on Alzheimer’s disease and diabetes mellitus: threats, risks and treatment Alzheimer’s disease and diabetes mellitus. Curr Alzheimer Res 15, 1277–1282.10.2174/1567205015666180925110222CrossRefGoogle ScholarPubMed
Chibowska, K, Baranowska-Bosiacka, I, Falkowska, A, et al. (2016) Effect of lead (Pb) on inflammatory processes in the brain. Int J Mol Sci 17, E2140.10.3390/ijms17122140CrossRefGoogle ScholarPubMed
Struzynska, L, Dabrowska-Bouta, B, Koza, K, et al. (2007) Inflammation-like glial response in lead-exposed immature rat brain. Toxicol Sci 95, 156–162.10.1093/toxsci/kfl134CrossRefGoogle ScholarPubMed
Van Wijngaarden, E, Winters, PC & Cory-Slechta, DA (2011) Blood lead levels in relation to cognitive function in older U.S. adults. Neurotoxicol 32, 110–115.10.1016/j.neuro.2010.11.002CrossRefGoogle ScholarPubMed
Vlasak, T, Jordakieva, G, Gnambs, T, et al. (2019) Blood lead levels and cognitive functioning: a meta-analysis. Sci Total Environ 668, 678–684.10.1016/j.scitotenv.2019.03.052CrossRefGoogle ScholarPubMed
Shalan, MG, Mostafa, MS, Hassouna, MM, et al. (2005) Amelioration of lead toxicity on rat liver with Vitamin C and silymarin supplements. Toxicology 206, 1–15.10.1016/j.tox.2004.07.006CrossRefGoogle ScholarPubMed
Vij, AG, Satija, NK & Flora, SJ (1998) Lead induced disorders in hematopoietic and drug metabolizing enzyme system and their protection by ascorbic acid supplementation. Biomed Environ Sci 11, 7–14.Google ScholarPubMed
Alissa, EM & Ferns, GA (2011) Heavy metal poisoning and cardiovascular disease. J Toxicol 2011, 870125.10.1155/2011/870125CrossRefGoogle ScholarPubMed
Tinkov, AA, Filippini, T, Ajsuvakova, OP, et al. (2017) The role of cadmium in obesity and diabetes. Sci Total Environ 601–602, 741–755.10.1016/j.scitotenv.2017.05.224CrossRefGoogle ScholarPubMed
Kodl, CT & Seaquist, ER (2008) Cognitive dysfunction and diabetes mellitus. Endocr Rev 29, 494–511.10.1210/er.2007-0034CrossRefGoogle ScholarPubMed
Iadecola, C & Gottesman, RF (2019) Neurovascular and cognitive dysfunction in hypertension. Circ Res 124, 1025–1044.10.1161/CIRCRESAHA.118.313260CrossRefGoogle ScholarPubMed
Kim, J, Garcia-Esquinas, E, Navas-Acien, A, et al. (2018) Blood and urine cadmium concentrations and walking speed in middle-aged and older U.S. adults. Environ Pollut 232, 97–104.10.1016/j.envpol.2017.09.022CrossRefGoogle ScholarPubMed
Chou, MY, Nishita, Y, Nakagawa, T, et al. (2019) Role of gait speed and grip strength in predicting 10-year cognitive decline among community-dwelling older people. BMC Geriatr 19, 186.10.1186/s12877-019-1199-7CrossRefGoogle ScholarPubMed
Beauchet, O, Annweiler, C, Callisaya, ML, et al. (2016) Poor gait performance and prediction of dementia: results from a meta-analysis. J Am Med Dir Assoc 17, 482–490.10.1016/j.jamda.2015.12.092CrossRefGoogle ScholarPubMed
Li, H, Wang, Z, Fu, Z, et al. (2018) Associations between blood cadmium levels and cognitive function in a cross-sectional study of US adults aged 60 years or older. BMJ Open 8, e020533.10.1136/bmjopen-2017-020533CrossRefGoogle ScholarPubMed
Karri, V, Schuhmacher, M & Kumar, V (2016) Heavy metals (Pb, Cd, As and MeHg) as risk factors for cognitive dysfunction: a general review of metal mixture mechanism in brain. Environ Toxicol Pharmacol 48, 203–213.10.1016/j.etap.2016.09.016CrossRefGoogle ScholarPubMed
Karami, A, Darreh-Shori, T, Schultzberg, M, et al. (2021) CSF and plasma cholinergic markers in patients with cognitive impairment. Front Aging Neurosci 13, 704583.10.3389/fnagi.2021.704583CrossRefGoogle ScholarPubMed
Genchi, G, Sinicropi, MS, Lauria, G, et al. (2020) The effects of cadmium toxicity. Int J Environ Res Public Health 17, 3782.10.3390/ijerph17113782CrossRefGoogle ScholarPubMed
Moyano, P, de Frias, M, Lobo, M, et al. (2018) Cadmium induced ROS alters M1 and M3 receptors, leading to SN56 cholinergic neuronal loss, through AChE variants disruption. Toxicol 394, 54–62.10.1016/j.tox.2017.12.006CrossRefGoogle ScholarPubMed
Aschner, M, Erikson, KM, Hernández, EH, et al. (2009) Manganese and its role in Parkinson’s disease: from transport to neuropathology. Neuromol Med 11, 252–266.10.1007/s12017-009-8083-0CrossRefGoogle ScholarPubMed
Balachandran, RC, Mukhopadhyay, S, McBride, D, et al. (2020) Brain manganese and the balance between essential roles and neurotoxicity. J Biol Chem 295, 6312–6329.10.1074/jbc.REV119.009453CrossRefGoogle ScholarPubMed
Carmona, A, Zogzas, CE, Roudeau, S, et al. (2019) SLC30A10 mutation involved in parkinsonism results in Manganese accumulation within nanovesicles of the golgi apparatus. ACS Chem Neurosci 10, 599–609.10.1021/acschemneuro.8b00451CrossRefGoogle ScholarPubMed
Chakraborty, P (2017) Mercury exposure and Alzheimer’s disease in India - an imminent threat? Sci Total Environ 589, 232–235.10.1016/j.scitotenv.2017.02.168CrossRefGoogle ScholarPubMed
Cabral Pinto, MMS, Marinho-Reis, P, Almeida, A, et al. (2019) Links between cognitive status and trace element levels in hair for an environmentally exposed population: a case study in the surroundings of the Estarreja Industrial Area. Int J Environ Res Public Health 16, 4560.10.3390/ijerph16224560CrossRefGoogle ScholarPubMed
Satarug, S, Garrett, SH, Sens, MA, et al. (2010) Cadmium, environmental exposure, and health outcomes. Environ Health Perspect 118, 182–190.10.1289/ehp.0901234CrossRefGoogle ScholarPubMed